FAK/PYK2 inhibitors defactinib and VS-4718 enhance immune checkpoint inhibitor efficacy

Title
FAK/PYK2 inhibitors defactinib and VS-4718 enhance immune checkpoint inhibitor efficacy
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 3, Issue Suppl 2, Pages P354
Publisher
Springer Nature
Online
2015-11-05
DOI
10.1186/2051-1426-3-s2-p354

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started